These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6318114)

  • 21. Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure.
    Haydon D; Lea S; Fry L; Knowles N; Samuel AR; Stuart D; Woolhouse ME
    J Mol Evol; 1998 Apr; 46(4):465-75. PubMed ID: 9541542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67.
    Lea S; Abu-Ghazaleh R; Blakemore W; Curry S; Fry E; Jackson T; King A; Logan D; Newman J; Stuart D
    Structure; 1995 Jun; 3(6):571-80. PubMed ID: 8590018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants.
    Butchaiah G; Morgan DO
    Virus Res; 1997 Dec; 52(2):183-94. PubMed ID: 9495534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of amino acid sequences at the amino acid 130-160 region of VP1 polypeptide of Indian field isolates of foot-and-mouth disease virus serotype Asia 1.
    Sanyal A; Gurumurthy CB; Venkataramanan R; Hemadri D; Tosh C
    Acta Virol; 2000 Apr; 44(2):85-90. PubMed ID: 10989699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.
    Verdaguer N; Sevilla N; Valero ML; Stuart D; Brocchi E; Andreu D; Giralt E; Domingo E; Mateu MG; Fita I
    J Virol; 1998 Jan; 72(1):739-48. PubMed ID: 9420281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
    Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
    Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foot-and-mouth disease virus subtyping by sequencing VP1 genes.
    Marquardt O; Adam KH
    Vet Microbiol; 1990 Jun; 23(1-4):175-83. PubMed ID: 2169671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleotide sequence of the VP1 gene of the foot-and-mouth disease virus strain A Venceslau.
    Cheung A; Whitehead P; Weiss S; Küpper H
    Gene; 1984 Oct; 30(1-3):241-5. PubMed ID: 6096217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotechnological approach to a new foot-and-mouth disease virus vaccine.
    Küpper H
    Biotechnol Genet Eng Rev; 1984; 1():223-59. PubMed ID: 6085855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging foot-and-mouth disease virus variants with antigenically critical amino acid substitutions predicted by model studies using reference viruses.
    Feigelstock DA; Mateu MG; Valero ML; Andreu D; Domingo E; Palma EL
    Vaccine; 1996 Feb; 14(2):97-102. PubMed ID: 8852403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus.
    van Rensburg HG; Nel LH
    Virus Genes; 1999; 19(3):229-33. PubMed ID: 10595414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.
    Mateu MG; Martínez MA; Rocha E; Andreu D; Parejo J; Giralt E; Sobrino F; Domingo E
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5883-7. PubMed ID: 2474821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.
    Cheung A; DeLamarter J; Weiss S; Küpper H
    J Virol; 1983 Nov; 48(2):451-9. PubMed ID: 6194313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment.
    Martín V; Perales C; Abia D; Ortíz AR; Domingo E; Briones C
    BMC Genomics; 2006 May; 7():117. PubMed ID: 16709242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis.
    Cooke JN; Westover KM
    Infect Genet Evol; 2008 Dec; 8(6):855-63. PubMed ID: 18790086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus.
    Martín MJ; Núñez JI; Sobrino F; Dopazo J
    J Virol Methods; 1998 Oct; 74(2):215-21. PubMed ID: 9779622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance.
    Borrego B; Camarero JA; Mateu MG; Domingo E
    Viral Immunol; 1995; 8(1):11-8. PubMed ID: 8546800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.